{
    "clinical_study": {
        "@rank": "87455", 
        "acronym": "LEG", 
        "arm_group": {
            "arm_group_label": "Single Arm: Lutonix Drug Coated Balloon"
        }, 
        "brief_summary": {
            "textblock": "The registry will enroll patients with claudication or critical limb ischemia and\n      angiographically significant lesion(s) in arteries of the lower extremity.  Subjects will be\n      treated with the Lutonix\u00ae Drug Coated Balloon Catheter for approved indications according to\n      the current country-specific Instructions for Use (IFU) and followed clinically for 2 years."
        }, 
        "brief_title": "Use and Safety of the LUTONIX\u00ae Drug Coated Balloon Catheter in Arteries of the Lower Extremity", 
        "completion_date": {
            "#text": "June 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Peripheral Artery Disease", 
        "condition_browse": {
            "mesh_term": "Peripheral Arterial Disease"
        }, 
        "detailed_description": {
            "textblock": "This post-market registry is intended to assess the clinical use and safety of the Lutonix\u00ae\n      Drug Coated Balloon Catheter in a heterogeneous patient population in real world clinical\n      practice. Up to 500 patients will be enrolled in order to allow identification and\n      assessment of rare adverse events (AEs) as well as outcomes in subpopulations defined by\n      subject and lesion characteristics. All subjects will be followed for 2 years.\n\n      This registry is performed with marketed devices within the indications for use. There are\n      no additional treatments or exams that will take place within this registry."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. \u2265 18 years of age;\n\n          2. Rutherford Clinical Category \u2264 5;\n\n          3. Patient or Legally Authorized Representative is willing to provide informed consent\n             and comply with the required follow up;\n\n          4. Stenotic or obstructive vascular lesions in artery(s) of the lower extremity;\n\n          5. Lesion(s) can be treated with available LUTONIX Drug Coated Balloon Catheter device\n             size matrix per current country-specific IFU.\n\n        Exclusion Criteria:\n\n          1. Patient is currently participating in an active phase of another investigational drug\n             or device study;\n\n          2. Inability to take recommended medications as stated in the IFU or non-controllable\n             allergy to contrast."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Real-world patients requiring drug coated balloon treatment."
            }
        }, 
        "enrollment": {
            "#text": "500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 17, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02043951", 
            "org_study_id": "CL0015-01"
        }, 
        "intervention": {
            "arm_group_label": "Single Arm: Lutonix Drug Coated Balloon", 
            "intervention_name": "Lutonix Drug Coated Balloon Catheter", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 27, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Tauranga", 
                    "country": "New Zealand"
                }, 
                "name": "Bay Radiology Ltd Tauranga"
            }, 
            "investigator": {
                "last_name": "Gerard Eagar, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "New Zealand"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Prospective, Multicenter, Single Arm, Post-Market, Real-World Global Registry Assessing the Clinical Use and Safety of the LUTONIX Drug Coated Balloon Catheter in Arteries of the Lower Extremity (LUTONIX\u00ae Lower Extremity Global (LEG) Registry)", 
        "overall_contact": {
            "email": "Rudy.Padua@crbard.com", 
            "last_name": "Rudy Padua"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Malaysia: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "June 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Efficacy: Freedom from target lesion revascularization (TLR)", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "description": "Freedom from the composite endpoint of target vessel revascularization (TVR), major amputation and major reintervention (new bypass graft, jump/interposition graft revision, or thrombectomy/thrombolysis) of index limb and device- and procedure-related death.", 
                "measure": "Safety", 
                "safety_issue": "Yes", 
                "time_frame": "30 Days"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02043951"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Device success is defined as, a per device basis, the achievement of successful delivery and deployment of the registry device(s) as intended at the intended target lesion, without balloon rupture or inflation/deflation abnormalities and a successful withdrawal of the registry system. If a device is inserted into the subject but not used due to user error (e.g. inappropriate balloon length or transit time too long) this device will not be included in the device success assessment.", 
                "measure": "Acute Device Success", 
                "safety_issue": "No", 
                "time_frame": "30 days, 6, 12, and 24 months"
            }, 
            {
                "description": "Attainment of \u226430% residual stenosis by visual estimate in the treatment area above the knee and attainment of \u226450% residual stenosis by visual estimate in the treatment area below the knee without major adverse events during the index procedure.", 
                "measure": "Procedural Success", 
                "safety_issue": "No", 
                "time_frame": "30 days, 6, 12, and 24 months"
            }, 
            {
                "description": "All-cause death\nDevice- and procedure-related mortality\nUnexpected device or drug-related AEs\nUnplanned index limb amputation (major and minor reported separately)\nReintervention for treatment of thrombosis of the target vessel\nReintervention for embolization to its distal vasculature\nTLR (at 6 and 24 months)\nTVR\nComposite of all-cause perioperative (\u226430 day) death and from the following: index limb amputation, index limb reintervention, and index-limb-related death\nMajor amputation and major reintervention (new bypass graft, jump/interposition graft revision, or thrombectomy/thrombolysis) of index limb.", 
                "measure": "Freedom separately from each of the following adverse events listed below:", 
                "safety_issue": "No", 
                "time_frame": "30 days, 6, 12, and 24 months"
            }
        ], 
        "source": "C. R. Bard", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "C. R. Bard", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "2 Years", 
        "verification_date": "March 2014"
    }
}